Title: TOXINS: CREATING A SAFER TOMORROW
1TOXINS CREATING A SAFER TOMORROW
- Maricel V. Maffini, Ph.D
- Tufts University School of Medicine
- Wellesley (MA) 5/12/2009
2Theo Colborn, zoologist, writer
From the day of conception until an individual
is born or hatched, the development of each stage
of life is fully under the control of hormones.
Changes that happen during development are far
less reversible than those occurring in an
adult you can't go back and rewire the brain.
3Hormone-associated diseases/disorders
- Breast cancer
- Testicular cancer
- Prostate cancer
- Decrease quantity and quality of sperm
- Male genital tract defects (hypospadias,
cryptorchydism) - Infertility rates affects at least 11 of
American couples of reproductive age (10 million
couples). Causes 51 female, 49 male-associated
4The endocrine system
- - GROWTH
- - METABOLISM (FAT, SUGAR)
- - REPRODUCTIVE HEALTH
- LACTATION
- BRAIN DEVELOPMENT
- FETAL DEVELOPMENT
- PUBERTY
Testosterone Estrogen Progesterone Thyroid
Hormone Insulin Growth hormone Prolactin
5The endocrine system
Testosterone Estrogen Progesterone Thyroid
Hormone Insulin Growth hormone Prolactin
- - GROWTH
- - METABOLISM (FAT, SUGAR)
- - REPRODUCTIVE HEALTH
- LACTATION
- BRAIN DEVELOPMENT
Endocrine Disruptors
6The EPA definition
An endocrine disruptor is an exogenous agent
that interferes with the synthesis, secretion,
transport, binding, action, or elimination of
natural hormones in the body that are responsible
for the maintenance of homeostasis, reproduction,
development, and/or behavior.
7World Health Organization goes further
- An endocrine disruptor is an exogenous
substance or mixture that alters function(s) of
the endocrine system and consequently causes
adverse health effects in an intact organism, or
its progeny, or (sub)populations.
Global assessment of the state-of-the-science of
endocrine disruptors. International Program on
Chemical Safety, World Health Organization
(2002).
8WHY ARE THESE CHANGES IMPORTANT?
- We are not exposed to single chemicals
- Time of exposure or windows of vulnerability
(fetal development, puberty) - Differential sensitivity
- Chronic exposure
- Effects can be carried through generations
- Declining in population(s) size, gender ratio,
etc.
9EXAMPLES OF ENDOCRINE DISRUPTORS
NATURAL PHYTOESTROGENS ANIMAL HORMONES
SYNTHETIC/MAN-MADE DESIGNED CHEMICALS PETROLEOUM
BY-PRODUCTS
- Estrogen agonists/antagonists (DDT, BPA, DEHP,
Parabens) - Androgen agonists/antagonists (Vinclozoline,
Phthalates) - Thyroid disrupting agents (PCBs)
- Disruptors of hormone metabolism/synthesis
(Atrazine)
10FRAGANCES, DETERGENTS
STORAGE, WRAPPING, PACKAGING
FLAME RETARDANTS
PESTICIDES, FERTILIZERS
SUNSCREENS
PLASTICS
11ENDOCRINE DISRUPTORS AND HUMAN HEALTH
121976-SEVESO (ITALY)POPULATION EXPOSURE TO DIOXIN
- Cohort women who were infant to 40 years old at
time of exposure - Individual serum dioxin relates with breast
cancer incidence - Breast cancer risk increases with increase in
serum dioxin
Warner et al. EHP, 2002
131976-SEVESO (ITALY)POPULATION EXPOSURE TO DIOXIN
- Cohort women that were lt30 years old
- Women with higher levels of serum dioxin have
higher risk of endometriosis
Eskenazi et al. EHP, 2002
141976-SEVESO (ITALY)POPULATION EXPOSURE TO DIOXIN
- Cohort all women were premenopausal at the time
of the explosion - Statistically significant trend toward earlier
menopause - There is a nonmonotonic (inverted U-shape)
dose-related association with increasing risk of
earlier menopause
Eskenazi et al. EHP, 2005
15DDT
- Pesticide widely introduced in the USA in 1945,
peak use in 1959 - Banned in 1972 (affected wildlife)
- Potent estrogen-mimic
Women under 20 years of age at the time of DDT
exposure have 5 times greater risk of developing
breast cancer
Many women heavily exposed in childhood have
not reached age 50
Cohn et al. EHP, 2007
16DES (diethylstilbestrol)
Given to between 2 and 10 million pregnant women
in the US between the years of 1948 and 1971.
DES treatment was banned in the US in 1971, but
continued to be used in other countries until the
1980s.
printed in the American Journal of Obstetrics
Gynecology in 1957.
17The DES daughters (1-2 million)
- Women with prenatal exposure to DES have an
increased risk of breast cancer after age 40
years (Palmer et al. Cancer Epidemiol Biomarker
Prev, 2006) - DES-exposed women were 50 more likely to
experience menopause at any given age. This
effect was dose dependent (Hatch et al. Am J
Epidemiology, 2006)
18DES legacy
- Women exposed in utero developed a rare carcinoma
of the vagina, had malformations of their genital
tracts (H-shaped uteri), and abnormally shaped
Fallopian tubes. - Decreased ability to support pregnancy.
- Men exposed in utero had malformations of their
genital tracts undescended testes, small testes,
and cysts of the epididymus - Their sperm quality was decreased and episodes of
infertility increased.
Functional consequences of DES exposure became
evident after puberty
19OTHER HEALTH PROBLEMS ASSOCIATED WITH ENDOCRINE
DISRUPTORS EXPOSURE
20Pediatrics, American Academy of Pediatrics, 2008
- Data are sufficient to suggest a trend toward an
earlier breast development onset and menarche in
girls but not for other female pubertal markers. - Current data for boys are insufficient to
evaluate secular trends in male pubertal
development - - Altered puberty timing should be considered an
adverse effect.
ADVANCED PUBERTY IN GIRLS
21Environmental Health Perspective, 2005
- The higher the levels of phthalates in the
mothers urine, the shorter the ano-genital
distance in boys. Anogenital is androgen
dependent and is twice as long in males as in
females - - Boys with short AGD also had one or both
testicles incompletely descended and a scrotum
that was small or not distinct from surrounding
tissue
22Environmental Health Perspective, 2007
- In this national cross-section of U.S. men,
concentrations of several prevalent phthalate
metabolites showed statistically significant
correlations with abdominal obesity and insulin
resistance - Our findings would suggest that
exposure to these phthalates may contribute to
the population burden of obesity, insulin
resistance, and related clinical disorders.
23PHTHALATE EXPOSURE
- Phthalates are widely used and can be found in
- Personal care use (makeup, shampoo, soaps)
- Plastics
- Paints
- Some pesticides
24ASSOCIATION OF URINARY BISPHENOL-A (BPA) WITH
MEDICAL DISORDERS
- Data from the National Health and Nutrition
Examination Survey (NHANES) 2003-2004 - 1455 adults (age 18-74 years)
- urinary concentration of BPA
- markers of liver function
- glucose homeostasis
- inflammation
- lipid changes
- Higher urinary BPA was associated with
cardiovascular diagnosis, diabetes, liver function
Lang et al. JAMA, 2008
25BPA in the American population
Calafat et al. Environmental Health Perspectives.
Available online Oct 24, 2007
- BPA was detected in the urine of 92.6 of the
population (2,500 people tested) - Children have higher levels than adolescents
- Adolescents have higher levels than adults
- Women have higher levels than men
- Non-hispanic whites and non-hispanic blacks have
higher levels than Mexican-Americans - High income households have lowest levels of BPA
gt
gt
26THE ORIGIN OF BPA
1891 CHEMIST SINTHESIZED BPA IN LAB
1930s DISCOVERED TO BE AN ESTROGEN, REPLACED BY
DES
1940s 1950s USED TO MANUFACTURE POLYCARBONATE
PLASTIC AND EPOXY RESINS
TO DATE COUNTLESS NUMBER OF CONSUMER PRODUCTS
CONTAIN BPA MULTIBILLION DOLLAR INDUSTRY
27BPA IS REGULATED BY US EPA
1988 A SAFETY STANDARD (OR REFERENCE DOSE) FOR
BPA WAS SET AT 50 MICROGRAMS/KILOGRAM BODY
WEIGHT/DAY THIS IS THE CURRENT DOSE CONSIDERED
SAFE
28Sources of BPA exposure
- Polycarbonate plastics
- Baby bottles
- Water bottles
- Water carboys, food containers
- Epoxy resins
- Dental sealants composites
- Lacquer coating of food cans (baby formula)
- Household glues, electrical insulation, water
pipes, - wine storage vats
- Human exposure
- Present in over 90 of urine samples analyzed by
CDC - Placenta
- Fetal plasma
- Amniotic fluid
- Ovarian fluid
- Breast milk
Chronic exposure to low environmental levels
29BPA AND BREAST CANCER
30THE MAJORITY OF BREAST CANCERS (90-95) ARE NOT
ASSOCIATED WITH FAMILY HISTORY OF BREAST OR ANY
OTHER CANCERS.
311940
321960
33Hormones and breast cancer
There is one aspect of the disease everybody
agrees on an increased cumulative lifetime
exposure to endogenous estrogen increases the
risk of developing breast cancer
- Early age at menarche (lt12 years old)
- Late age at menopause (gt55 years old)
- Prenatal estrogen exposure (twin births vs
pre-eclampsia)
342007
35CRITICAL PERIODS DURING BREAST DEVELOPMENT
1- gestation 2- puberty
36WHY IS GESTATION A CRITICAL PERIOD?
- AN INDIVIDUAL IS BEEN FORMED
- EVERY ORGAN AND SYSTEM IN THE BODY IS FORMED (it
takes 9 months in humans, 20 days in mice) - COMPLEX COMMUNICATION NETWORKS ARE ESTABLISHED
- PERFECT AND EXQUISITE BALANCE OF HORMONES ARE
NECESSARY - TIMING IS KEY
IMBALANCES (TOO MUCH, TOO LITTLE, AT THE WRONG
TIME) HAVE LONG LASTING CONSEQUENCES THAT
MANIFEST AT DIFFERENT TIMES DURING THE
INDIVIDUALS LIFETIME
37WHY IS PUBERTY A CRITICAL PERIOD?
5 days
20 days
30 days
PUBERTY
The rodent mammary gland
38PUMP
- gestation - gestationlactation
PREGNANCY
BPA
39DOES BPA HAVE ANY EFFECT AT THE TIME OF EXPOSURE?
40Perinatal exposure to BPA
EFFECTS ON THE MAMMARY GLAND
NO-TREATED
1- accelerates the growth of
fetal mammary gland 2- fetal glands are
larger and longer 3-
certain aspects of development are
delayed
BPA-TREATED
41Perinatal exposure to BPA
EFFECTS ON THE MAMMARY GLAND 1- alterations in
shape and size can be seen at 1, 3, 4, 6, 9, 15
months of age 2- glands of virgin animals look
like those from pregnant ones
control 25ng BPA
250ng BPA
6 months 1 month
TD
42BPA exposure through lactation leads to dense
epithelium at 3 months
gestation
gestation lactation
control
250ng BPA
43Perinatal exposure to BPA
EFFECTS ON THE MAMMARY GLAND 1- mice developed
pre-cancerous lesions 2- rats developed carcinoma
in situ and pre-cancerous lesions
NO TREATMENT
BPA-TREATED MOUSE
BPA-TREATED RAT
NORMAL
PRE-CANCEROUS
CANCER
44BPA-exposed rats have increased tumor
susceptibility
BPA 250
BPA 2.5
BPA 1000
45Comparing the EPA safe dose with the
experimental doses
EPA safe dose 50 microgram/kg/day (50ug)
46WHAT CAN ANIMALS TELL US?
- 1981 Fetal DES exposure increased the propensity
of the rat mammary gland to undergo neoplastic
development. - 2006 Breast cancer incidence is increased in
women exposed in utero to DES. - 2006 Prenatal exposure to BPA increases the
vulnerability of the rat and mouse mammary gland
to develop pre-tumoral lesions and carcinomas in
situ. - Will breast cancer incidence be found to
increase in women exposed to BPA in utero in the
next decades?
47BPA exposure and the link with breast cancer
- Increased mammary density
- Increased number of structures where cancers are
thought to originate - Increased sensitivity to estrogen
- Presence of intraductal hyperplasias and
carcinomas in situ
Markey et al, 2001 Munoz de Toro et al,
2005 Wadia et al, 2007
48Effects of perinatal BPA exposure
- Advanced puberty
- Altered estrous cycles and early cessation of
cyclic activity - Altered ovarian morphology
- Quantitative changes on the expression of ERa and
PR in the uterus - Altered social, sexual and maternal behavior
49BPA AND THE BRAIN
50BPA AND THE BRAIN
511. Defeminization of sexually dimorphic areas 2.
Increased male behavior
52Hyperactivity
53Obsessive behavior
54Effects of perinatal BPA exposure
- Increased prostate size
- Increased risk of prostate cancer
- Increased frequency of eggs with chromosomal
aberrations - Alters body weight
- Alters male infant behavior towards its mother
(monkey) - Interferes with spine synapse formation (monkey)
55What can we do?
- The easy things
- Avoid plastics and do not expose them to heat
- Minimize the consumption of canned food
- Buy organic food and hormone-free meats and dairy
- Wash fruits and vegetables thoroughly
- Use pesticide-free lawn care
- Choose eco-friendly cleaning products
- Reduce exposure of babies and young girls to
personal care products (fragrances, cosmetics)
56WHAT CAN WE DO?
- Be informed
- www.cdc.gov/exposurereport
- www.cdc.gov/exposurereport/pdf/factsheet_phthalate
s.pdf - www.ewg.org/reports/infantformula
- www.ourstolenfuture.org
- www.silentspring.org
- http//sciencereview.silentspring.org/index.cfm
- www.ewg.org
- www.cosmeticsdatabase.com
- Ask questions
- Express your concerns
57(No Transcript)
58SKIN DEEP COSMETIC SAFETY DATABASE
59SKIN DEEP COSMETIC SAFETY DATABASE
60What can we do?
- The hard things
- Use the precautionary principle
61Government of Canada Protects Families With
Bisphenol A Regulations News Release2008-167Octo
ber 17, 2008 The Government of Canada today
announced it will immediately proceed with
drafting regulations to prohibit the importation,
sale and advertising of polycarbonate baby
bottles that contain bisphenol A (BPA). The
Government will also take action to limit the
amount of bisphenol A that is being released into
the environment.
62What can we do?
- The hard things
- Use the precautionary principle
- Hold corporations accountable
63Sunoco restricts sales of chemical used in
bottlesBy MATTHEW PERRONE, AP Business Writer
Matthew Perrone, Ap Business Writer Thu Mar 12,
415 pm ETWASHINGTON Sunoco has begun
restricting sales of a controversial chemical
used in baby bottles and food containers that
some researchers believe can harm infants.The
move by the gas and chemical giant makes Sunoco
the first manufacturer to acknowledge safety
concerns about bisphenol-A, or BPA, which
recently led retailers like Wal-Mart to pull
thousands of baby and water bottles off store
shelves.In light of that uncertainty, Sunoco
said in a letter Thursday it has begun requiring
customers to guarantee that its BPA will not be
used in food and water containers for children
under 3."We will no longer sell BPA to
customers who cannot make this promise," Thomas
Golembeski, head of public relations, wrote in a
letter to two investors.
64Seeking Safer Packaging is a project of Green
Century Capital Management, Inc. (Green Century)
and As You Sow. The authors sent letters to 20
companies in the packaged food industry to
identify the actions the companies are taking to
address concerns regarding BPA. Fourteen
companies replied. Company scores are based
entirely on their responses to these letters.
65Our main findings include All companies
surveyed use BPA and are taking insufficient
steps to move toward alternatives. Hain
Celestial, Heinz, and Nestlé received the top
scores because all three companies are involved
in researching and testing of alternatives to BPA
and all have plans to phase out the chemical in
some products. Heinz stands out as a leader as
it is the only company surveyed that is currently
using an alternative to BPA in some of its can
linings. Three of the companies that responded
to our questions, Del Monte, Hershey, and J.M.
Smucker, are not taking action beyond monitoring
the industry to identify or implement
alternatives to BPA as a packaging material.
66What can we do?
- The hard things
- Use the precautionary principle
- Hold corporations accountable
- Change the way testing is done by regulatory
agencies - Develop better testing methods to assess total
body burden
67UNIVERSITY OF GRANADA (SPAIN)CASE CONTROL STUDY
- The total xenoestrogen burden (combined load of
xenoestrogens in fat measured by the E-SCREEN
assay) correlates positively with breast cancer
in post-menopausal women.
68What can we do?
- The hard things
- Use the precautionary principle
- Hold corporations accountable
- Change the way testing is done by regulatory
agencies - Develop better testing methods to assess total
body burden - Educate the public and health care professionals
about risks and ways to prevent unnecessary
exposures - Start talking about prevention
69Bisphenol A Toxic Plastics Chemical in Canned
Food Companies reduced BPA exposures in Japan
(http//www.ewg.org/node/20938)
Environmental Health Perspective, 2003
Changes in the composition of can coating
70The National Toxicology Program Report
- In April 2008
- The NTP concurs with the conclusion of the CERHR
Expert Panel on bisphenol-A that there is some
concern for neural and behavioral effects in
fetuses, infants, and children at current human
exposures. The NPT also has some concern for
bisphenol-A exposure in these populations based
on effects in the prostate gland, mammary gland,
and an earlier age for puberty in females - In June 2008
- The levels of concern for effects on the mammary
gland and puberty were downgraded to minimal
71The U.S. Food and Drug Administration Report
- In April 2008, the FDA task force released the
following statement - Based on our ongoing review, we believe there is
a large body of evidence that indicates that
FDA-regulated products containing BPA currently
on the market are safe and that exposure levels
to BPA from food contact materials, including for
infants and children, are below those that may
cause health effects.
72The U.S. Food and Drug Administration Report
- Fall 2008, a FDA Scientific Advisory Subcommittee
released the following statement - Coupling together the available qualitative and
quantitative information (including the
application of uncertainty factors) provides a
sufficient scientific basis to conclude that the
margins of safety defined by the FDA as
adequate are, in fact, inadequate
73August 14, 2008 WASHINGTON, D.C. President
Bush signed a federal bill today that bans six
toxic phthalates from childrens products. The
measure is officially known as the Consumer
Product Safety Improvement Act of 2008 Six
types of phthalates, chemicals linked to genital
defects in males, have been banned from toys
along with lead. The phthalate provision makes
three phthalates permanently illegal and three
others temporarily illegal until the CPSC can
determine whether the chemicals are safe or
dangerous.http//www.consumeraffairs.com In
2007, California, Washington and Vermont
restricted phthalate use in childrens products.
74Mar 16, 2009 Suffolk County Unanimously Passes
First BPA Baby Bottle Bill Suffolk County, NY,
has become the first jurisdiction in the nation
to ban bisphenol A in baby bottles and sippy
cups. The countys legislature passed the ban
with a unanimous vote on Tuesday. April 3,
2009 Suffolk County Executive Steve Levy
announced this afternoon that he has signed the
first in the nation ban on the sale of empty
beverage containers (baby bottles and cups)
containing Bisphenol-A.
75March 17th, 2009 BPA Ban Introduced U.S.
Lawmakers Follow Canada and Europe in Outlawing
Toxic Plastic Chemical United States lawmakers
have taken the first steps toward banning the use
of a toxic chemical blamed for causing
developmental problems in children from baby
bottles and other beverage containers. Two bills
have been introduced into the House of
Representatives and the Senate to establish a
federal ban on bisphenol A (BPA) in all food and
beverage containers. The legislation has not yet
been debated or subjected to a vote. The new
bills, sponsored by Rep. Edward Markey (D-Mass.)
and Sens. Dianne Feinstein (D-Calif.) and Chuck
Schumer (D-N.Y.), follow various efforts to limit
the use of BPA in baby bottles.
76ttp//www.nytimes.com/2009/05/10/nyregion/connecti
cut/10bpact.html?_r1refpolicy Measure to
Restrict BPA Moving to State Senate
By MARGARET FARLEY STEELE Published May
6, 2009 Under the Connecticut legislation,
infant formula and baby food stored in cans,
plastic containers or jars containing BPA could
no longer be made or sold in the state as of
October 2011. Baby bottles, sippy cups and
reusable food and beverage containers like sports
bottles with BPA would also be phased out. Other
food containers that use BPA liners, including
most canned goods, would have to carry a
conspicuous warning on the label.
77Acknowledgements
Beverly Rubin
Carlos Sonnenschein
78Rachel Carson biologist, writer, ecologist
(1907-1964)
On April 3, 1963, the Columbia Broadcasting
System's television series "C.B.S. Reports"
presented the program "The Silent Spring of
Rachel Carson." In it, Miss Carson said "It is
the public that is being asked to assume the
risks that the insect controllers calculate. The
public must decide whether it wishes to continue
on the present road, and it can do so only when
in full possession of the facts.